About this study

Methamphetamine and alcohol are commonly consumed in combination, with the resulting effects on thinking and behaviour making driving under the influence of these drugs very dangerous. Despite this, no research has yet investigated how these drugs might interact to affect behaviour and performance relevant to road safety.

This trial aims to assess the direct effect of combined usage of low (legal) doses of alcohol combined with d-methamphetamine on:

  • higher order cognitive function and neurobehavioral functioning
  • driving performance
  • ocular activity


You may be eligible to participate if you:

  • are aged 21–40
  • are a non-smoker
  • have a full drivers licence
  • have used amphetamines in the past
  • have no pre-existing medical conditions

Note: Additional eligibility criteria may apply to participate in this study.
 

What’s involved?

Participation will involve attending the Centre for Human Psychopharmacology on five separate occasions: 

  • one screening session for approximately 1.5 hours
  • four testing sessions, one week apart, for three hours each.


You will be reimbursed for your time and travel expenses upon completion of the study.

If you’re interested in participating, please complete the form below and we will be in touch.

Complete the registration form to participate

For further enquiries

Dr Amie Hayley

+61 3 9214 5585

ahayley@swinburne.edu.au

Our research ethics and integrity

Our researchers are committed to the highest ethical, professional and scholarly standards. All our studies conform to the Australian Code for the Responsible Conduct of Research, Good Clinical Practice and the National Statement on Ethical Conduct in Human Research.

Contact the Centre for Human Psychopharmacology

There are many ways to engage with us. If your organisation is dealing with a complex problem, get in touch to discuss how we can work together to provide solutions. Call us on +61 3 9214 4444 or email chp@swinburne.edu.au.

Contact us